B. Metzler Seel. Sohn & Co. Ag Insmed Inc Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $10 Billion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Insmed Inc stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 10,510 shares of INSM stock, worth $768,806. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,510Holding current value
$768,806% of portfolio
0.01%Shares
7 transactions
Others Institutions Holding INSM
# of Institutions
465Shares Held
182MCall Options Held
2.27MPut Options Held
3.33M-
Vanguard Group Inc Valley Forge, PA17.1MShares$1.25 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.04 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.6MShares$920 Million0.11% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y910.5MShares$768 Million62.32% of portfolio
-
Capital International Investors Los Angeles, CA6.52MShares$477 Million0.09% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.91B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...